Nektar Therapeutics (NKTR)
68.55
-0.94
(-1.35%)
USD |
NASDAQ |
May 21, 16:00
68.55
0.00 (0.00%)
After-Hours: 19:34
Nektar Therapeutics Research and Development Expense (TTM) : 122.50M for March 31, 2026
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Eli Lilly & Co. | 14.11B |
| Aquestive Therapeutics, Inc. | 16.04M |
| Boston Scientific Corp. | 2.125B |
| Esperion Therapeutics, Inc. | 44.28M |
| Corcept Therapeutics, Inc. | 260.44M |